Ignite Creation Date:
2024-05-06 @ 12:21 AM
Last Modification Date:
2024-10-26 @ 10:48 AM
Study NCT ID:
NCT01553071
Status:
TERMINATED
Last Update Posted:
2022-03-31
First Post:
2012-03-07
Brief Title:
Phase I Trial of IV Fenretinide 4-HPR Plus IV Safingol for Patients With Relapsed Malignancies
Sponsor:
South Plains Oncology Consortium
Organization:
South Plains Oncology Consortium
Organization Data
Organization:
South Plains Oncology Consortium
Class:
NETWORK
Study ID:
SPOC-2010-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
South Plains Oncology Consortium
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None